Dr. Carlos Portera-Cailliau investigates synaptic and circuit changes in the mouse model of Fragile X syndrome in his lab at the UCLA David Geffen School of Medicine, where he is on faculty. He has received grants from the NIH, the Dana Foundation, the March of Dimes Foundation, the Simons Foundation, and the John Merck Fund. From 2013 to 2021 he was the co-director of the UCLA-Caltech medical Scientist Training Program. He still sees patients in the movement disorders clinic.
Dr. Santoro serves as the Director of Neuroimmunology and Demyelinating Disorders Program at Children’s Hospital Los Angeles. He is also an assistant professor of neurology at the Keck School of Medicine at USC. Santoro has been instrumental in identifying systemic vascular abnormalities in persons with Down syndrome and moyamoya disease, a rare stroke disorder which affects persons with Down syndrome 26 times more frequently than the general population. Santoro also has clinical research expertise in inflammation as it related to cerebrovascular disease and neurocognitive disorders such as Down syndrome regression syndrome, of which he spoken on internationally.
Dr. Stephen Scherer’s research includes understanding the composition of the human genome for studies of genetic disease built around three themes: 1) gene copy number and structural variation in the human genome, 2) determining the genetic architecture in autism spectrum and related- disorders and using this information to help families, and 3) developing infrastructure and capacity in Canada for translational genomics research.
Dr. Peng is a member of both the Structural Biology and Developmental Neurobiology departments at St. Jude and serves as the director of the Center for Proteomics and Metabolomics. His research involves using mass spectrometry-based proteomics, metabolomics and systems biology to understand mechanisms of human disease.